Andrzej Mogielnicki

1.2k total citations
46 papers, 1.0k citations indexed

About

Andrzej Mogielnicki is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Andrzej Mogielnicki has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 11 papers in Pharmacology. Recurrent topics in Andrzej Mogielnicki's work include Heparin-Induced Thrombocytopenia and Thrombosis (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). Andrzej Mogielnicki is often cited by papers focused on Heparin-Induced Thrombocytopenia and Thrombosis (15 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Venous Thromboembolism Diagnosis and Management (11 papers). Andrzej Mogielnicki collaborates with scholars based in Poland, Japan and France. Andrzej Mogielnicki's co-authors include Karol Kramkowski, W Buczko, Włodzimierz Buczko, Bartłomiej Kałaska, Emilia Sokołowska, Stefan Chłopicki, Ewa Chabielska, Magdalena Łomnicka, Jerzy Gębicki and Jan Adamus and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Andrzej Mogielnicki

44 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej Mogielnicki Poland 18 316 290 203 133 123 46 1.0k
Marilena Crescente United Kingdom 19 343 1.1× 249 0.9× 148 0.7× 64 0.5× 204 1.7× 40 1.2k
Jiro Seki Japan 19 232 0.7× 351 1.2× 231 1.1× 138 1.0× 256 2.1× 66 1.2k
Takeo Tanaka Japan 25 360 1.1× 611 2.1× 253 1.2× 179 1.3× 41 0.3× 82 1.6k
Lucia Stefanini Italy 23 340 1.1× 379 1.3× 192 0.9× 83 0.6× 747 6.1× 47 1.5k
T. Stief Germany 18 118 0.4× 223 0.8× 144 0.7× 150 1.1× 330 2.7× 98 1.2k
Edward M. Driscoll United States 19 512 1.6× 201 0.7× 113 0.6× 118 0.9× 117 1.0× 41 1.1k
Andrea Leone‐Bay United States 20 95 0.3× 282 1.0× 223 1.1× 35 0.3× 73 0.6× 43 1.0k
Siamak Davani France 15 186 0.6× 275 0.9× 276 1.4× 54 0.4× 41 0.3× 44 960
Agnieszka Jasztal Poland 21 159 0.5× 364 1.3× 125 0.6× 168 1.3× 24 0.2× 61 1.1k
Shinsuke Mii Japan 21 150 0.5× 780 2.7× 715 3.5× 263 2.0× 37 0.3× 99 1.9k

Countries citing papers authored by Andrzej Mogielnicki

Since Specialization
Citations

This map shows the geographic impact of Andrzej Mogielnicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Mogielnicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Mogielnicki more than expected).

Fields of papers citing papers by Andrzej Mogielnicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Mogielnicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Mogielnicki. The network helps show where Andrzej Mogielnicki may publish in the future.

Co-authorship network of co-authors of Andrzej Mogielnicki

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Mogielnicki. A scholar is included among the top collaborators of Andrzej Mogielnicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Mogielnicki. Andrzej Mogielnicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonarek, Piotr, Kamil Kamiński, Shin‐ichi Yusa, et al.. (2024). Synthesis, Biological Evaluation and Reversal of Sulfonated Di‐ and Triblock Copolymers as Novel Parenteral Anticoagulants. Advanced Healthcare Materials. 13(31). e2402191–e2402191. 2 indexed citations
2.
Kamiński, Kamil, et al.. (2023). Anionic and cationic block copolymers as promising modulators of blood coagulation. European Polymer Journal. 199. 112452–112452. 3 indexed citations
3.
Bonarek, Piotr, Małgorzata Opydo‐Chanek, Elżbieta Kołaczkowska, et al.. (2023). Biological Properties of Heparins Modified with an Arylazopyrazole-Based Photoswitch. Journal of Medicinal Chemistry. 66(3). 1778–1789. 2 indexed citations
4.
Kałaska, Bartłomiej, Kamil Kamiński, Shin‐ichi Yusa, et al.. (2022). Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins. Journal of Clinical Medicine. 11(8). 2236–2236. 4 indexed citations
5.
Kałaska, Bartłomiej, et al.. (2022). The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats. Vaccine. 40(13). 1996–2002. 2 indexed citations
6.
Kałaska, Bartłomiej, et al.. (2021). Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models. Pharmaceutics. 13(3). 359–359. 5 indexed citations
7.
Kałaska, Bartłomiej, et al.. (2021). Monitoring of Cardiorespiratory Parameters in Rats—Validation Based on Pharmacological Stimulation. Pharmaceuticals. 14(12). 1223–1223. 2 indexed citations
8.
Yusa, Shin‐ichi, et al.. (2021). Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice. International Journal of Molecular Sciences. 22(20). 11149–11149. 1 indexed citations
9.
Kałaska, Bartłomiej, Kamil Kamiński, Shin‐ichi Yusa, et al.. (2020). Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats. Journal of Pharmacology and Experimental Therapeutics. 373(1). 51–61. 10 indexed citations
10.
Kałaska, Bartłomiej, Kamil Kamiński, Małgorzata Rusak, et al.. (2019). The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents. Marine Drugs. 17(9). 539–539. 7 indexed citations
11.
Kałaska, Bartłomiej, Kamil Kamiński, Keita Nakai, et al.. (2018). Anticoagulant Properties of Poly(sodium 2-(acrylamido)-2-methylpropanesulfonate)-Based Di- and Triblock Polymers. Biomacromolecules. 19(7). 3104–3118. 19 indexed citations
12.
Kałaska, Bartłomiej, Kamil Kamiński, Shin‐ichi Yusa, et al.. (2016). Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice. Translational research. 177. 98–112.e10. 24 indexed citations
13.
Sokołowska, Emilia, Bartłomiej Kałaska, Kamil Kamiński, et al.. (2016). The Toxicokinetic Profile of Dex40-GTMAC3—a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Frontiers in Pharmacology. 7. 60–60. 18 indexed citations
14.
Kałaska, Bartłomiej, Kamil Kamiński, Emilia Sokołowska, et al.. (2015). Nonclinical Evaluation of Novel Cationically Modified Polysaccharide Antidotes for Unfractionated Heparin. PLoS ONE. 10(3). e0119486–e0119486. 28 indexed citations
15.
Kramkowski, Karol, Agnieszka Leszczyńska, Andrzej Mogielnicki, et al.. (2012). Antithrombotic Properties of Water-Soluble Carbon Monoxide-Releasing Molecules. Arteriosclerosis Thrombosis and Vascular Biology. 32(9). 2149–2157. 51 indexed citations
16.
Pietrzak, Lucyna, Andrzej Mogielnicki, & W Buczko. (2009). Nicotinamide and its metaboliteN-methylnicotinamide increase skin vascular permeability in rats. Clinical and Experimental Dermatology. 34(3). 380–384. 16 indexed citations
17.
Chłopicki, Stefan, J Świȩs, Andrzej Mogielnicki, et al.. (2007). 1‐Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti‐thrombotic activity mediated by a cyclooxygenase‐2/prostacyclin pathway. British Journal of Pharmacology. 152(2). 230–239. 172 indexed citations
18.
Stankiewicz, Adrian, Andrzej Mogielnicki, Anna Gromotowicz‐Poplawska, et al.. (2007). A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. Thrombosis and Haemostasis. 97(6). 1037–1045. 11 indexed citations
19.
Kramkowski, Karol, et al.. (2005). The effect of ‘tissue’ and ‘plasma’ angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats. Thrombosis Research. 117(5). 557–561. 6 indexed citations
20.
Buczko, Włodzimierz, Andrzej Mogielnicki, Karol Kramkowski, & Ewa Chabielska. (2003). Aspirin and the fibrinolytic response. Thrombosis Research. 110(5-6). 331–334. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilena Crescente Breakdown of academic impact, for papers by Jiro Seki Breakdown of academic impact, for papers by Takeo Tanaka Breakdown of academic impact, for papers by Lucia Stefanini Breakdown of academic impact, for papers by T. Stief Breakdown of academic impact, for papers by Edward M. Driscoll Breakdown of academic impact, for papers by Andrea Leone‐Bay Breakdown of academic impact, for papers by Siamak Davani Breakdown of academic impact, for papers by Agnieszka Jasztal Breakdown of academic impact, for papers by Shinsuke Mii
Rankless by CCL
2026